Skip to main content
. 2019;20(10):3121–3127. doi: 10.31557/APJCP.2019.20.10.3121

Table 6.

Cumulative Overall Survival of AML Patients Included in the Study

Number Cumulative
Significance
O.S at 6th month P- value
SALL4 Gene Expression
≤ 1.0 RQ 22 59.10%
> 1.0 RQ 30 76.20% 0.18
Whole group 52 68.90%